Nopneu is creating a paradigmn shift in infant mortality. Every year, pneumonia kills more children than measles, malaria, and AIDS combined. Through innovative biotechnology, a diagnostic test allows users, without specialized knowledge, to more effectively diagnose pneumonia in a fraction of the time and cost of conventional methods used in hospitals. Nopneu is committed to changing the larger systemic issues that influence infant mortality through sharing stories and building communities. A percentage of their profits are donated to outreach efforts and organizations that are committed to addressing these social determinants.